+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Albumin Market By Type, By Application, By Sales Channel: Global Opportunity Analysis and Industry Forecast, 2023-2032

  • PDF Icon

    Report

  • 287 Pages
  • January 2024
  • Region: Global
  • Allied Market Research
  • ID: 5578198
The albumin market was valued at $ 5.40 billion in 2022 and is estimated to reach $ 9.90 billion by 2032, exhibiting a CAGR of 6.2% from 2023 to 2032. Albumin is a crucial protein found in the blood plasma, playing a fundamental role in maintaining osmotic pressure and transporting various substances throughout the body. Comprising about 60% of total plasma proteins, albumin is synthesized by the liver and possesses a unique structure that allows it to bind to diverse molecules like hormones, drugs, and nutrients. This versatile protein contributes significantly to fluid balance, preventing excessive leakage of fluids from blood vessels into tissues. In addition, albumin serves as a carrier for essential fatty acids and helps regulate pH levels in the blood. Its multifaceted functions make albumin indispensable for overall physiological well-being.

The factor driving the growth of the albumin market is the increase in global burden of disease conditions such as cardiovascular diseases, cancer, diabetes, and liver disorder. For instance, according to American cancer Society, in 2022, there were approximately 1.9 million new cancer cases diagnosed in the U.S. Albumin, with its versatile applications, plays a crucial role in cancer treatment. It serves as a carrier for oncologic drugs, improving drug solubility and enhancing targeted delivery to cancer cells. Moreover, albumin's use in maintaining fluid balance during chemotherapy underscores its importance in supporting patients. The increasing prevalence of cancer and other diseases globally amplifies the demand for albumin products, illustrating its crucial contributions to addressing multifaceted health concerns.

Furthermore, the growth of the albumin market is propelled by the increasing implementation of key strategies among major industry players, including product launches, acquisitions, and agreements. For instance, in September 2020, Sartorius Group, a leading international partner of life science research and the biopharmaceutical industry, announced acquisition of Albumedix Ltd, a leader in the field of recombinant albumin-based solutions. In addition, Grifols, a leading global producer of plasma-derived medicines, announced the launch of its latest albumin portfolio innovation, ALBUTEIN FlexBag (Albumin [Human] U.S.P.) in 5% and 25% concentrations. These strategic moves not only drive innovation but also foster market growth by catering to the evolving needs of the healthcare and biopharmaceutical industries.

In addition, technological advancements are key drivers of the growing albumin market. In the pharmaceutical and biotechnology sectors, continuous innovations in production processes and purification techniques enhance the efficiency and quality of albumin products. Advanced technologies also contribute to the development of novel albumin-based formulations, expanding their applications in drug delivery systems and diagnostics. Precision in manufacturing, purification, and analysis ensures high-quality albumin with minimal impurities, meeting stringent regulatory standards. In addition, technological progress facilitates the exploration of alternative sources for albumin production, addressing supply chain challenges. The synergy between technology and albumin production not only improves existing products but also fosters the creation of cutting-edge solutions, fueling the overall expansion of the albumin market.

The albumin market is segmented on the basis of type, application, sales channel, and region. On the basis of type, the market is categorized into human serum albumin, bovine serum albumin, and recombinant albumin. On the basis of application, it is classified into therapeutics, drug formulation & vaccines, component of media, and others. On the basis of sales channel, it is classified into business to business (B2B) and business to consumer (B2C). On the basis of region, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

The major key players that operate in the global albumin market are Takeda Pharmaceutical Company Limited, Merck KGaA, Sartorius AG, Octapharma AG, Thermo Fisher Scientific Inc., Ventria Bioscience Inc, Grifols, S.A., CSL, China Biologic Products Holdings, Inc, and Lazuline Bio. The players have adopted investment, strategic alliance, product approval, clinical trials, expansion, agreement, and acquisition as the key strategies to expand their product portfolio.

Key Benefits For Stakeholders

  • This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the albumin market analysis from 2022 to 2032 to identify the prevailing albumin market opportunities.
  • The market research is offered along with information related to key drivers, restraints, and opportunities.
  • Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
  • In-depth analysis of the albumin market segmentation assists to determine the prevailing market opportunities.
  • Major countries in each region are mapped according to their revenue contribution to the global market.
  • Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
  • The report includes the analysis of the regional as well as global albumin market trends, key players, market segments, application areas, and market growth strategies.

Additional benefits you will get with this purchase are:

  • Quarterly Update and* (only available with a corporate license, on listed price)
  • 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
  • Free Upcoming Version on the Purchase of Five and Enterprise User License.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Five and Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Patient/epidemiology data at country, region, global level
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Expanded list for Company Profiles
  • Historic market data
  • Reimbursement Scenario
  • SWOT Analysis

Key Market Segments

By Type

  • Human Serum Albumin
  • Bovine Serum Albumin
  • Recombinant Albumin

By Application

  • Therapeutics
  • Drug Formulation and Vaccines
  • Component of Media
  • Other

By Sales Channel

  • B2C
  • B2B
  • Type
  • Pharmaceutical Applications
◦ Type
  • Non Pharmaceutical Applications
◦ Type

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players

  • Octapharma AG
  • Grifols, S.A.
  • CSL
  • Ventria Bioscience Inc.
  • Lazuline Bio
  • Takeda Pharmaceutical Company Limited
  • Sartorius AG
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • China Biologic Products Holdings, Inc

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter’s five forces analysis
3.3.1. Moderate bargaining power of suppliers
3.3.2. Moderate threat of new entrants
3.3.3. Moderate threat of substitutes
3.3.4. Moderate intensity of rivalry
3.3.5. Moderate bargaining power of buyers
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in number of surgical procedures
3.4.1.2. Growing awareness regarding blood donations.
3.4.1.3. Rise in use of plasma derived albumin in drug development
3.4.2. Restraints
3.4.2.1. Stringent government regulations
3.4.3. Opportunities
3.4.3.1. Growth opportunities in emerging markets
CHAPTER 4: ALBUMIN MARKET, BY TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Human Serum Albumin
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Bovine Serum Albumin
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Recombinant Albumin
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: ALBUMIN MARKET, BY APPLICATION
5.1. Overview
5.1.1. Market size and forecast
5.2. Therapeutics
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Drug Formulation and Vaccines
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Component of Media
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Other
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: ALBUMIN MARKET, BY SALES CHANNEL
6.1. Overview
6.1.1. Market size and forecast
6.2. B2C
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. B2B
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.3.4. B2B Albumin Market by Type
6.3.4.1. Pharmaceutical Applications Albumin Market by Type
6.3.4.2. Non Pharmaceutical Applications Albumin Market by Type
CHAPTER 7: ALBUMIN MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key market trends, growth factors and opportunities
7.2.2. Market size and forecast, by Type
7.2.3. Market size and forecast, by Application
7.2.4. Market size and forecast, by Sales Channel
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Market size and forecast, by Type
7.2.5.1.2. Market size and forecast, by Application
7.2.5.1.3. Market size and forecast, by Sales Channel
7.2.5.2. Canada
7.2.5.2.1. Market size and forecast, by Type
7.2.5.2.2. Market size and forecast, by Application
7.2.5.2.3. Market size and forecast, by Sales Channel
7.2.5.3. Mexico
7.2.5.3.1. Market size and forecast, by Type
7.2.5.3.2. Market size and forecast, by Application
7.2.5.3.3. Market size and forecast, by Sales Channel
7.3. Europe
7.3.1. Key market trends, growth factors and opportunities
7.3.2. Market size and forecast, by Type
7.3.3. Market size and forecast, by Application
7.3.4. Market size and forecast, by Sales Channel
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Market size and forecast, by Type
7.3.5.1.2. Market size and forecast, by Application
7.3.5.1.3. Market size and forecast, by Sales Channel
7.3.5.2. France
7.3.5.2.1. Market size and forecast, by Type
7.3.5.2.2. Market size and forecast, by Application
7.3.5.2.3. Market size and forecast, by Sales Channel
7.3.5.3. UK
7.3.5.3.1. Market size and forecast, by Type
7.3.5.3.2. Market size and forecast, by Application
7.3.5.3.3. Market size and forecast, by Sales Channel
7.3.5.4. Italy
7.3.5.4.1. Market size and forecast, by Type
7.3.5.4.2. Market size and forecast, by Application
7.3.5.4.3. Market size and forecast, by Sales Channel
7.3.5.5. Spain
7.3.5.5.1. Market size and forecast, by Type
7.3.5.5.2. Market size and forecast, by Application
7.3.5.5.3. Market size and forecast, by Sales Channel
7.3.5.6. Rest of Europe
7.3.5.6.1. Market size and forecast, by Type
7.3.5.6.2. Market size and forecast, by Application
7.3.5.6.3. Market size and forecast, by Sales Channel
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors and opportunities
7.4.2. Market size and forecast, by Type
7.4.3. Market size and forecast, by Application
7.4.4. Market size and forecast, by Sales Channel
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Market size and forecast, by Type
7.4.5.1.2. Market size and forecast, by Application
7.4.5.1.3. Market size and forecast, by Sales Channel
7.4.5.2. China
7.4.5.2.1. Market size and forecast, by Type
7.4.5.2.2. Market size and forecast, by Application
7.4.5.2.3. Market size and forecast, by Sales Channel
7.4.5.3. India
7.4.5.3.1. Market size and forecast, by Type
7.4.5.3.2. Market size and forecast, by Application
7.4.5.3.3. Market size and forecast, by Sales Channel
7.4.5.4. Australia
7.4.5.4.1. Market size and forecast, by Type
7.4.5.4.2. Market size and forecast, by Application
7.4.5.4.3. Market size and forecast, by Sales Channel
7.4.5.5. South Korea
7.4.5.5.1. Market size and forecast, by Type
7.4.5.5.2. Market size and forecast, by Application
7.4.5.5.3. Market size and forecast, by Sales Channel
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Market size and forecast, by Type
7.4.5.6.2. Market size and forecast, by Application
7.4.5.6.3. Market size and forecast, by Sales Channel
7.5. LAMEA
7.5.1. Key market trends, growth factors and opportunities
7.5.2. Market size and forecast, by Type
7.5.3. Market size and forecast, by Application
7.5.4. Market size and forecast, by Sales Channel
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Market size and forecast, by Type
7.5.5.1.2. Market size and forecast, by Application
7.5.5.1.3. Market size and forecast, by Sales Channel
7.5.5.2. Saudi Arabia
7.5.5.2.1. Market size and forecast, by Type
7.5.5.2.2. Market size and forecast, by Application
7.5.5.2.3. Market size and forecast, by Sales Channel
7.5.5.3. South Africa
7.5.5.3.1. Market size and forecast, by Type
7.5.5.3.2. Market size and forecast, by Application
7.5.5.3.3. Market size and forecast, by Sales Channel
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Market size and forecast, by Type
7.5.5.4.2. Market size and forecast, by Application
7.5.5.4.3. Market size and forecast, by Sales Channel
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product mapping of top 10 player
8.4. Competitive dashboard
8.5. Competitive heatmap
8.6. Top player positioning, 2022
CHAPTER 9: COMPANY PROFILES
9.1. Merck KGaA
9.1.1. Company overview
9.1.2. Key executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.1.6. Business performance
9.2. Sartorius AG
9.2.1. Company overview
9.2.2. Key executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.2.6. Business performance
9.2.7. Key strategic moves and developments
9.3. Octapharma AG
9.3.1. Company overview
9.3.2. Key executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.3.6. Business performance
9.3.7. Key strategic moves and developments
9.4. Thermo Fisher Scientific Inc.
9.4.1. Company overview
9.4.2. Key executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.4.6. Business performance
9.5. Ventria Bioscience Inc.
9.5.1. Company overview
9.5.2. Key executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.6. Grifols, S.A.
9.6.1. Company overview
9.6.2. Key executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.6.6. Business performance
9.6.7. Key strategic moves and developments
9.7. CSL
9.7.1. Company overview
9.7.2. Key executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.7.6. Business performance
9.8. China Biologic Products Holdings, Inc
9.8.1. Company overview
9.8.2. Key executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.9. Lazuline Bio
9.9.1. Company overview
9.9.2. Key executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.10. Takeda Pharmaceutical Company Limited
9.10.1. Company overview
9.10.2. Key executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio
9.10.6. Business performance
9.10.7. Key strategic moves and developments
List of Tables
Table 01. Global Albumin Market, by Type, 2022-2032 ($Million)
Table 02. Albumin Market for Human Serum Albumin, by Region, 2022-2032 ($Million)
Table 03. Albumin Market for Bovine Serum Albumin, by Region, 2022-2032 ($Million)
Table 04. Albumin Market for Recombinant Albumin, by Region, 2022-2032 ($Million)
Table 05. Global Albumin Market, by Application, 2022-2032 ($Million)
Table 06. Albumin Market for Therapeutics, by Region, 2022-2032 ($Million)
Table 07. Albumin Market for Drug Formulation and Vaccines, by Region, 2022-2032 ($Million)
Table 08. Albumin Market for Component of Media, by Region, 2022-2032 ($Million)
Table 09. Albumin Market for Other, by Region, 2022-2032 ($Million)
Table 10. Global Albumin Market, by Sales Channel, 2022-2032 ($Million)
Table 11. Albumin Market for B2C, by Region, 2022-2032 ($Million)
Table 12. Albumin Market for B2B, by Region, 2022-2032 ($Million)
Table 13. Global B2B Albumin Market, by Type, 2022-2032 ($Million)
Table 14. Global Pharmaceutical Applications Albumin Market, by Type, 2022-2032 ($Million)
Table 15. Global Non Pharmaceutical Applications Albumin Market, by Type, 2022-2032 ($Million)
Table 16. Albumin Market, by Region, 2022-2032 ($Million)
Table 17. North America Albumin Market, by Type, 2022-2032 ($Million)
Table 18. North America Albumin Market, by Application, 2022-2032 ($Million)
Table 19. North America Albumin Market, by Sales Channel, 2022-2032 ($Million)
Table 20. North America Albumin Market, by Country, 2022-2032 ($Million)
Table 21. U.S. Albumin Market, by Type, 2022-2032 ($Million)
Table 22. U.S. Albumin Market, by Application, 2022-2032 ($Million)
Table 23. U.S. Albumin Market, by Sales Channel, 2022-2032 ($Million)
Table 24. Canada Albumin Market, by Type, 2022-2032 ($Million)
Table 25. Canada Albumin Market, by Application, 2022-2032 ($Million)
Table 26. Canada Albumin Market, by Sales Channel, 2022-2032 ($Million)
Table 27. Mexico Albumin Market, by Type, 2022-2032 ($Million)
Table 28. Mexico Albumin Market, by Application, 2022-2032 ($Million)
Table 29. Mexico Albumin Market, by Sales Channel, 2022-2032 ($Million)
Table 30. Europe Albumin Market, by Type, 2022-2032 ($Million)
Table 31. Europe Albumin Market, by Application, 2022-2032 ($Million)
Table 32. Europe Albumin Market, by Sales Channel, 2022-2032 ($Million)
Table 33. Europe Albumin Market, by Country, 2022-2032 ($Million)
Table 34. Germany Albumin Market, by Type, 2022-2032 ($Million)
Table 35. Germany Albumin Market, by Application, 2022-2032 ($Million)
Table 36. Germany Albumin Market, by Sales Channel, 2022-2032 ($Million)
Table 37. France Albumin Market, by Type, 2022-2032 ($Million)
Table 38. France Albumin Market, by Application, 2022-2032 ($Million)
Table 39. France Albumin Market, by Sales Channel, 2022-2032 ($Million)
Table 40. UK Albumin Market, by Type, 2022-2032 ($Million)
Table 41. UK Albumin Market, by Application, 2022-2032 ($Million)
Table 42. UK Albumin Market, by Sales Channel, 2022-2032 ($Million)
Table 43. Italy Albumin Market, by Type, 2022-2032 ($Million)
Table 44. Italy Albumin Market, by Application, 2022-2032 ($Million)
Table 45. Italy Albumin Market, by Sales Channel, 2022-2032 ($Million)
Table 46. Spain Albumin Market, by Type, 2022-2032 ($Million)
Table 47. Spain Albumin Market, by Application, 2022-2032 ($Million)
Table 48. Spain Albumin Market, by Sales Channel, 2022-2032 ($Million)
Table 49. Rest of Europe Albumin Market, by Type, 2022-2032 ($Million)
Table 50. Rest of Europe Albumin Market, by Application, 2022-2032 ($Million)
Table 51. Rest of Europe Albumin Market, by Sales Channel, 2022-2032 ($Million)
Table 52. Asia-Pacific Albumin Market, by Type, 2022-2032 ($Million)
Table 53. Asia-Pacific Albumin Market, by Application, 2022-2032 ($Million)
Table 54. Asia-Pacific Albumin Market, by Sales Channel, 2022-2032 ($Million)
Table 55. Asia-Pacific Albumin Market, by Country, 2022-2032 ($Million)
Table 56. Japan Albumin Market, by Type, 2022-2032 ($Million)
Table 57. Japan Albumin Market, by Application, 2022-2032 ($Million)
Table 58. Japan Albumin Market, by Sales Channel, 2022-2032 ($Million)
Table 59. China Albumin Market, by Type, 2022-2032 ($Million)
Table 60. China Albumin Market, by Application, 2022-2032 ($Million)
Table 61. China Albumin Market, by Sales Channel, 2022-2032 ($Million)
Table 62. India Albumin Market, by Type, 2022-2032 ($Million)
Table 63. India Albumin Market, by Application, 2022-2032 ($Million)
Table 64. India Albumin Market, by Sales Channel, 2022-2032 ($Million)
Table 65. Australia Albumin Market, by Type, 2022-2032 ($Million)
Table 66. Australia Albumin Market, by Application, 2022-2032 ($Million)
Table 67. Australia Albumin Market, by Sales Channel, 2022-2032 ($Million)
Table 68. South Korea Albumin Market, by Type, 2022-2032 ($Million)
Table 69. South Korea Albumin Market, by Application, 2022-2032 ($Million)
Table 70. South Korea Albumin Market, by Sales Channel, 2022-2032 ($Million)
Table 71. Rest of Asia-Pacific Albumin Market, by Type, 2022-2032 ($Million)
Table 72. Rest of Asia-Pacific Albumin Market, by Application, 2022-2032 ($Million)
Table 73. Rest of Asia-Pacific Albumin Market, by Sales Channel, 2022-2032 ($Million)
Table 74. LAMEA Albumin Market, by Type, 2022-2032 ($Million)
Table 75. LAMEA Albumin Market, by Application, 2022-2032 ($Million)
Table 76. LAMEA Albumin Market, by Sales Channel, 2022-2032 ($Million)
Table 77. LAMEA Albumin Market, by Country, 2022-2032 ($Million)
Table 78. Brazil Albumin Market, by Type, 2022-2032 ($Million)
Table 79. Brazil Albumin Market, by Application, 2022-2032 ($Million)
Table 80. Brazil Albumin Market, by Sales Channel, 2022-2032 ($Million)
Table 81. Saudi Arabia Albumin Market, by Type, 2022-2032 ($Million)
Table 82. Saudi Arabia Albumin Market, by Application, 2022-2032 ($Million)
Table 83. Saudi Arabia Albumin Market, by Sales Channel, 2022-2032 ($Million)
Table 84. South Africa Albumin Market, by Type, 2022-2032 ($Million)
Table 85. South Africa Albumin Market, by Application, 2022-2032 ($Million)
Table 86. South Africa Albumin Market, by Sales Channel, 2022-2032 ($Million)
Table 87. Rest of LAMEA Albumin Market, by Type, 2022-2032 ($Million)
Table 88. Rest of LAMEA Albumin Market, by Application, 2022-2032 ($Million)
Table 89. Rest of LAMEA Albumin Market, by Sales Channel, 2022-2032 ($Million)
Table 90. Merck KGaA: Key Executives
Table 91. Merck KGaA: Company Snapshot
Table 92. Merck KGaA: Product Segments
Table 93. Merck KGaA: Product Portfolio
Table 94. Sartorius AG: Key Executives
Table 95. Sartorius AG: Company Snapshot
Table 96. Sartorius AG: Product Segments
Table 97. Sartorius AG: Product Portfolio
Table 98. Sartorius AG: Key Strategies
Table 99. Octapharma AG: Key Executives
Table 100. Octapharma AG: Company Snapshot
Table 101. Octapharma AG: Product Segments
Table 102. Octapharma AG: Product Portfolio
Table 103. Octapharma AG: Key Strategies
Table 104. Thermo Fisher Scientific Inc. : Key Executives
Table 105. Thermo Fisher Scientific Inc. : Company Snapshot
Table 106. Thermo Fisher Scientific Inc. : Product Segments
Table 107. Thermo Fisher Scientific Inc. : Service Segments
Table 108. Thermo Fisher Scientific Inc. : Product Portfolio
Table 109. Ventria Bioscience Inc.: Key Executives
Table 110. Ventria Bioscience Inc.: Company Snapshot
Table 111. Ventria Bioscience Inc.: Product Segments
Table 112. Ventria Bioscience Inc.: Product Portfolio
Table 113. Grifols, SA: Key Executives
Table 114. Grifols, SA: Company Snapshot
Table 115. Grifols, SA: Product Segments
Table 116. Grifols, SA: Product Portfolio
Table 117. Grifols, SA: Key Strategies
Table 118. Csl: Key Executives
Table 119. Csl: Company Snapshot
Table 120. Csl: Product Segments
Table 121. Csl: Product Portfolio
Table 122. China Biologic Products Holdings, Inc.: Key Executives
Table 123. China Biologic Products Holdings, Inc.: Company Snapshot
Table 124. China Biologic Products Holdings, Inc.: Product Segments
Table 125. China Biologic Products Holdings, Inc.: Product Portfolio
Table 126. Lazuline Bio: Key Executives
Table 127. Lazuline Bio: Company Snapshot
Table 128. Lazuline Bio: Product Segments
Table 129. Lazuline Bio: Product Portfolio
Table 130. Takeda Pharmaceutical Company Limited: Key Executives
Table 131. Takeda Pharmaceutical Company Limited: Company Snapshot
Table 132. Takeda Pharmaceutical Company Limited: Product Segments
Table 133. Takeda Pharmaceutical Company Limited: Product Portfolio
Table 134. Takeda Pharmaceutical Company Limited: Key Strategies
List of Figures
Figure 01. Albumin Market, 2022-2032
Figure 02. Segmentation of Albumin Market,2022-2032
Figure 03. Top Impacting Factors in Albumin Market (2022 to 2032)
Figure 04. Top Investment Pockets in Albumin Market (2023-2032)
Figure 05. Moderate Bargaining Power of Suppliers
Figure 06. Moderate Threat of New Entrants
Figure 07. Moderate Threat of Substitutes
Figure 08. Moderate Intensity of Rivalry
Figure 09. Moderate Bargaining Power of Buyers
Figure 10. Global Albumin Market:Drivers, Restraints and Opportunities
Figure 11. Albumin Market, by Type, 2022 and 2032(%)
Figure 12. Comparative Share Analysis of Albumin Market for Human Serum Albumin, by Country 2022 and 2032(%)
Figure 13. Comparative Share Analysis of Albumin Market for Bovine Serum Albumin, by Country 2022 and 2032(%)
Figure 14. Comparative Share Analysis of Albumin Market for Recombinant Albumin, by Country 2022 and 2032(%)
Figure 15. Albumin Market, by Application, 2022 and 2032(%)
Figure 16. Comparative Share Analysis of Albumin Market for Therapeutics, by Country 2022 and 2032(%)
Figure 17. Comparative Share Analysis of Albumin Market for Drug Formulation and Vaccines, by Country 2022 and 2032(%)
Figure 18. Comparative Share Analysis of Albumin Market for Component of Media, by Country 2022 and 2032(%)
Figure 19. Comparative Share Analysis of Albumin Market for Other, by Country 2022 and 2032(%)
Figure 20. Albumin Market, by Sales Channel, 2022 and 2032(%)
Figure 21. Comparative Share Analysis of Albumin Market for B2C, by Country 2022 and 2032(%)
Figure 22. Comparative Share Analysis of Albumin Market for B2B, by Country 2022 and 2032(%)
Figure 23. Albumin Market by Region, 2022 and 2032(%)
Figure 24. U.S. Albumin Market, 2022-2032 ($Million)
Figure 25. Canada Albumin Market, 2022-2032 ($Million)
Figure 26. Mexico Albumin Market, 2022-2032 ($Million)
Figure 27. Germany Albumin Market, 2022-2032 ($Million)
Figure 28. France Albumin Market, 2022-2032 ($Million)
Figure 29. UK Albumin Market, 2022-2032 ($Million)
Figure 30. Italy Albumin Market, 2022-2032 ($Million)
Figure 31. Spain Albumin Market, 2022-2032 ($Million)
Figure 32. Rest of Europe Albumin Market, 2022-2032 ($Million)
Figure 33. Japan Albumin Market, 2022-2032 ($Million)
Figure 34. China Albumin Market, 2022-2032 ($Million)
Figure 35. India Albumin Market, 2022-2032 ($Million)
Figure 36. Australia Albumin Market, 2022-2032 ($Million)
Figure 37. South Korea Albumin Market, 2022-2032 ($Million)
Figure 38. Rest of Asia-Pacific Albumin Market, 2022-2032 ($Million)
Figure 39. Brazil Albumin Market, 2022-2032 ($Million)
Figure 40. Saudi Arabia Albumin Market, 2022-2032 ($Million)
Figure 41. South Africa Albumin Market, 2022-2032 ($Million)
Figure 42. Rest of LAMEA Albumin Market, 2022-2032 ($Million)
Figure 43. Top Winning Strategies, by Year (2020-2023)
Figure 44. Top Winning Strategies, by Development (2020-2023)
Figure 45. Top Winning Strategies, by Company (2020-2023)
Figure 46. Product Mapping of Top 10 Players
Figure 47. Competitive Dashboard
Figure 48. Competitive Heatmap: Albumin Market
Figure 49. Top Player Positioning, 2022
Figure 50. Merck KGaA: Net Sales, 2020-2022 ($Million)
Figure 51. Merck KGaA: Revenue Share by Segment, 2022 (%)
Figure 52. Merck KGaA: Revenue Share by Region, 2022 (%)
Figure 53. Sartorius AG: Net Sales, 2020-2022 ($Million)
Figure 54. Sartorius AG: Revenue Share by Segment, 2022 (%)
Figure 55. Sartorius AG: Revenue Share by Region, 2022 (%)
Figure 56. Octapharma AG: Sales Revenue, 2020-2022 ($Million)
Figure 57. Thermo Fisher Scientific Inc. : Net Revenue, 2020-2022 ($Million)
Figure 58. Thermo Fisher Scientific Inc. : Revenue Share by Segment, 2022 (%)
Figure 59. Thermo Fisher Scientific Inc. : Revenue Share by Region, 2022 (%)
Figure 60. Grifols, SA: Net Sales, 2020-2022 ($Million)
Figure 61. Grifols, SA: Revenue Share by Segment, 2022 (%)
Figure 62. Grifols, SA: Revenue Share by Region, 2022 (%)
Figure 63. Csl: Net Revenue, 2021-2023 ($Million)
Figure 64. Csl: Revenue Share by Segment, 2023 (%)
Figure 65. Csl: Revenue Share by Region, 2023 (%)
Figure 66. Takeda Pharmaceutical Company Limited: Net Revenue, 2021-2023 ($Million)
Figure 67. Takeda Pharmaceutical Company Limited: Revenue Share by Region, 2023 (%)

Companies Mentioned

  • Octapharma AG
  • Grifols, S.A.
  • CSL
  • Ventria Bioscience Inc.
  • Lazuline Bio
  • Takeda Pharmaceutical Company Limited
  • Sartorius AG
  • Merck KGaA
  • Thermo Fisher Scientific Inc.
  • China Biologic Products Holdings, Inc

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...